The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway

Figure 1

(a) Expression of eIF4A3 in glioma patients and non-diseased population in TCGA. (b) Expression level of eIF4A3 in glioma patients stratified by WHO grade in TCGA. (c) The expression of eIF4A3 protein in normal and glioma tissues according to the HPA database. (d, e) Survival analysis with eIF4A3 in glioma patients in TCGA.

(a)

(b)

(c)

(d)

(e)